Baxter International | مصاريف البيع والإدارة



Selling And Administration Expenses تغيير تاريخ
Abbott USD 3.05B 144M 2025-03
AtriCure USD 76.05M 3.87M 2025-03
Avanos Medical USD 79.6M 6.9M 2024-12
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Boston Scientific USD 1.6B 15M 2025-03
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Fresenius EUR 769M 68M 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
ICU Medical USD 158.54M 3.88M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 563.4M 49.2M 2025-03
J&J USD 5.11B 1.34B 2025-03
Laboratory Of America USD 546M 49.2M 2025-03
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merit Medical Systems USD 107.49M 4.91M 2025-03
Quest Diagnostics USD 476M 10M 2025-03
Smith & Nephew USD 1.35B 12.8M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 104.97M 871K 2025-03
Teleflex USD 222.71M 31.84M 2025-03
Terumo JPY 96.35B 3.76B 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Baxter International مصاريف البيع والإدارة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.